ScienceDex / Researcher record
John A Zebala
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,145,050 | 2 | #12,851 |
| 2025 | $1,531,122 | 2 | #9,770 |
| 2026 | $1,722,586 | 3 | #12,050 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20242 records
- FY20252 records
- FY2026 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 6765106Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award records by amount
NIH award records listing John A Zebala as a PI. Multi-PI records show the full award amount for context.
- 5R44CA291622-03R44Co-investigatorA Dose Expansion Study of SX-682 Alone and in Combination with Decitabine in MDS Patients$740.3Kaward amount
- 5R44CA278187-04R44Co-investigatorA Phase 2, Single-Arm Study of the CXCR1/2 Inhibitor SX-682 Plus Enzalutamide in Men with Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer (mCRPC)$575.8Kaward amount
- 1R44CA306688-01A1R44Co-investigatorA Phase 2 Study of SX-682 in Combination with Nivolumab and Relatlimab in Melanoma Patients$406.5Kaward amount
Award organization
Organizations that administered FY2026 awards listing John A Zebala as a PI.
FY2026 award administered by Syntrix Biosystems, Inc. (WA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardSyntrix Biosystems, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #9770
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as John A Zebala.